Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Philip Morris

Altria and Philip Morris have produced market-beating returns over the last 18 months. Nonetheless, one of these legacy tobacco companies is a far superior value stock.

Is Philip Morris or Altria the Better Value Stock?

ABM Industries

Abbott Labs

Black Hills

Emerson Electric

Federal Realty Investment Trust

Gorman-Rupp

Leggett & Platt

Lowe's

National Fuel Gas

Northwest Natural Gas

Stanley Black & Decker

Universal Corp

V.F.

"There is only one-criterion to be included among the Dividend Kings: A publicly-traded company must increase its total fiscal-year dividend payout for a minimum of 50 consecutive years." - Dogs of the Dow. The 47 Dividend Kings screened as of March 27, 2023, represented eight of 11 Morningstar Sectors. Broker targeted top 10 net gainers ranged 21.65%-59.78% topped by VFC and GRC.

6 April Dividend Kings To Buy, 5 To Watch

AbbVie

Johnson & Johnson

Mercedes-Benz Group AG

Suncor Energy

TotalEnergies SE

U.S. Bancorp

Toronto-Dominion Bank

Verizon

In today's article, I will present you with my top 10 high Dividend Yield stocks to invest in for April 2023. The 10 selected picks provide you with an attractive Dividend Yield, a relatively low Payout Ratio, as well as important competitive advantages and strong Financials.

My Top 10 High Dividend Yield Stocks To Invest In April 2023

Following its failed investment in Juul, Altria is exploring other smoke-free industries.

Altria Pivots Post-Juul: This Week in Cannabis Investing

Altria's dividend yield is a very generous 8.6%. The dividend has grown at a compound annual rate of 8% over the past decade.

How Long Can High-Yield Altria Continue to Grow Its Massive Dividend Payment?

Turning Point Brands

The Zacks Tobacco industry players are seeing low cigarette sales and commodity cost inflation. However, a focus on low-risk products and solid pricing bode well for Philip Morris (PM), Altria Group (MO) and Turning Point Brands (TPB).

3 Tobacco Stocks Worth Watching Despite Industry Headwinds

Crescent Point Energy

Magna International

Realty Income Corp

State Street

Teck Resources

Walgreens

When the Federal Reserve raised interest rates again by 25 basis points, investors seeking stable holdings needed to consider income stocks to buy. The Fed's benchmark rate is rising to a range of between 4.75% and 5.0%.

7 Must-Buy Income Stocks After the Fed Raised Interest Rates Again

Altria delivered their 2023 investor day and changed the premise around returning capital to shareholders and is abandoning the 80% of Adjusted EPS methodology. Altria is committed to dividend growth and has indicated that they see the dividend growing at a mid-single-digit rate annually through 2028.

Altria's Dividend Yields 8.49% And Is Committed To Future Dividend Growth

ASML Hld

British American Tobacco

Enterprise Products Partners

Legal & General Group PLC

Mastercard

Magellan Midstream Partners

MPLX

QUALCOMM

Taiwan Semiconductor Manufacturing

Visa

High-yield blue chips are beloved by retirees and for good reason. They can help you pay the bills without ever having to sell a single share. Nothing lets you sleep well at night in a bear market like not having to worry about price volatility.

12 Dividend Blue-Chip Bargains That Will Leave You Swimming In Cash

Best Stocks To Buy Today? 3 Top Dividend Stocks To Watch

The maker of Marlboro cigarettes is spending big on smoke-free products, but is committed to its payout.

Altria's CEO Explains Why the Dividend Is Big and Getting Bigger

Altria (MO) has been benefiting from its Oral Tobacco Products and strong pricing power. However, soft volumes in the Smokeable Products segment are a concern.

Altria's (MO) Smoke-Free Products Aid Amid Low Cigarette Volume

Arrow Financial

Enbridge

Essex Property Trust

First of Long Island

KFA Mount Lucas Index Strategy ETF

Old Republic International

Schwab US Dividend Equity ETF

T. Rowe Price Group

The banking crisis of 2023 is likely to push America into recession, possibly within four months. Stocks will likely sell off 15% to 30% before a new face-ripping bull market begins.

Retire Rich With This 6%-Yielding Dividend Aristocrat Portfolio

GlaxoSmithKline

LyondellBasell Industries

AT&T

I make a stock purchase every single month no matter what is going on in the world and despite the doom and gloom headlines. This month, I went heavier than I normally do, deploying over $3,000.

Recent Stock Purchase March 2023

Altria (MO) unveils 2028 Enterprise Goals, including corporate financial metrics and U.S. smoke-free portfolio goals. The company is building an impressive portfolio of smoke-free products.

Altria (MO) on Growth Track, Unveils 2028 Enterprise Goals

The maker of Marlboro cigarettes hopes to approximately double its total U.S. smoke-free net revenue by 2028.

Altria Believes Smoke-Free Products Could Double Revenue for the Growth Area

Altria Group, Inc (NYSE:MO), maker of Marlboro cigarettes, may expand its offering to include non-nicotine products including cannabis, according to a report in the Wall Street Journal. At an investor day on Thursday, the tobacco giant told investors that its 2028 investor goals include aspirations to compete beyond the US nicotine space.

Marlboro maker Altria considers cannabis as it ignites growth in smoke-free revenue

Marlboro cigarette parent Altria Group Inc. MO, -1.70% said it is considering expanding into non-nicotine offering, including cannabis and caffeine pouches, according to a report in The Wall Street Journal. Altria had said at its Investor Day Thursday that it targets at least 35% growth in U.S. smoke-free volumes by 2028, and to double total U.S. smoke-free revenue to $5 billion over the same time, with $2 billion coming from “innovative” smoke-free products, according to a FactSet transcript.

Marlboro cigarettes maker Altria looks to double its smoke-free revenue in 5 years, and considers expanding to cannabis and caffeine pouches, WSJ reports

Altria shares fell 3.7% on Thursday after its investor day, more than other tobacco stocks. They have fallen 17% in the past year. The dividend is moving from an 80% payout ratio to a mid-single-digit annual increase as EPS will likely become more volatile.

Altria: Multiple Disappointments From Investor Day

Altria Holds Investor Day; Introduces 2028 Enterprise Goals; Provides Updates on Product Development Efforts; Reaffirms 2023 Full-Year Earnings Guidance

Despite an already large exposure, it is sometimes tempting to execute certain trades. Getting paid to buy Altria at $44 is one such tempting trade, which I succumbed to.

Altria: The P/E Equals Yield Trade

Coterra Energy

The term ‘cash cow' refers to a company with significant market share in a mature industry. Typically, it requires minimal capital spending to maintain slow yet predictable growth.

Milk the Dividends on These 3 Cash Cows

Rio Tinto plc Sponsored

Equities have been going through a phase of uncertainty with a looming recession and aggressive contractionary monetary policies. The failure of Silicon Valley Bank has further dented equity market sentiments.

3 Stocks to Buy With a Dividend Yield of Over 5%

News for Altria Stock (MO)